|
A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (VOYAGE 1)
|
|
15-118-1
|
|
A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (VOYAGE 1)
|
|
Dr. Jun Lu
|
|
Study description not available
|
Other
|
|
Skin
|
|
|
Check with study contact
|
|
Cheryl Martin. Telephone: (860) 679-3475. Email: Cmartin@uchc.edu or Ektor Rafti. Telephone: 860-679-7021 Email: ERafti@uchc.edu
|
|
No longer enrolling
|
|
|